Overview

Assessment of Safety ,Tolerance and Pharmacokinetics Clinical Efficacy With BAT4706 in Advanced Solid Tumors

Status:
Recruiting
Trial end date:
2023-01-20
Target enrollment:
Participant gender:
Summary
A Phase I Clinical Study to Evaluate the Safety, Tolerance and Pharmacokinetics of BAT4706 Injection in Patients With Advanced Solid Tumors.
Phase:
Phase 1
Details
Lead Sponsor:
Bio-Thera Solutions
Collaborator:
Beijing Cancer Hospital